DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Serelaxin is an investigational drug.
There have been 14 clinical trials for Serelaxin. The most recent clinical trial was a Phase 3 trial, which was initiated on October 2nd 2013.
The most common disease conditions in clinical trials are Heart Failure, Liver Cirrhosis, and Hypertension, Portal. The leading clinical trial sponsors are Novartis Pharmaceuticals, Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies, and NHS Lothian.
There are thirty-two US patents protecting this investigational drug and seven hundred and forty-two international patents.
Recent Clinical Trials for Serelaxin
|Serelaxin To Lower Portal Pressure||NHS Lothian||Phase 2|
|Serelaxin To Lower Portal Pressure||Novartis Pharmaceuticals||Phase 2|
|Serelaxin To Lower Portal Pressure||University of Edinburgh||Phase 2|
Top disease conditions for Serelaxin
Top clinical trial sponsors for Serelaxin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Serelaxin||⤷ Sign up for a Free Trial||ANP fragment adjuvant therapy to standard of care (SOC) diuretic treatment||Madeleine Pharmaceuticals Pty Ltd. (Mount Barker, AU)||⤷ Sign up for a Free Trial|
|Serelaxin||⤷ Sign up for a Free Trial||sGC stimulators||Ironwood Pharmaceuticals, Inc. (Cambridge, MA)||⤷ Sign up for a Free Trial|
|Serelaxin||⤷ Sign up for a Free Trial||Modified relaxin B chain peptides||THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH (Parkville, Victoria, AU)||⤷ Sign up for a Free Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Serelaxin||Australia||AU2015230666||2034-04-09||⤷ Sign up for a Free Trial|
|Serelaxin||Australia||AU2015230778||2034-04-09||⤷ Sign up for a Free Trial|
|Serelaxin||European Patent Office||EP2968458||2033-03-15||⤷ Sign up for a Free Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|